Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Jin-Bor Chen"'
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2021 (2021)
BioMed Research International, Vol 2021 (2021)
Background. Encapsulating peritoneal sclerosis (EPS) is a rare but serious complication of peritoneal dialysis (PD). So far, there is no biomarker-based prediction tool available for EPS. Matrix metalloproteinase-2 (MMP-2) is a protein involved in th
Publikováno v:
Renal Failure, Vol 43, Iss 1, Pp 90-96 (2021)
Renal Failure
article-version (VoR) Version of Record
Renal Failure
article-version (VoR) Version of Record
Purpose This study aimed to investigate the association between clinical factors and temporary changes in functional performance in patients undergoing hemodialysis. Methods This was a retrospective, longitudinal observational study conducted from 20
Autor:
Jin-Bor Chen, Ying Liu, Jien-Wei Liu, Wen Xiu Chang, Li-Chueh Kuo, Chiao-Jung Chen, Ben-Chung Cheng
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-8 (2018)
BMC Nephrology
BMC Nephrology
Background The clinical course of Viridans streptococci (VS) peritonitis in patients undergoing peritoneal dialysis (PD) is rarely reported. This study examined the association of clinical factors with VS peritonitis. Methods We retrospectively revie
Autor:
Li-Chueh Kuo, Chien-Hsing Wu, Hong-Tao Yang, Jin-Bor Chen, Yang-Yang Lei, Pei-Ying Wang, Ben-Chung Cheng, Cheng-Hong Yang, Na Hao, Mei-Chen Chao, Sin-Hua Moi
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-6 (2019)
BMC Nephrology
BMC Nephrology
Background In this study, we investigated the association of time-varying serum albumin levels with mortality over a 5-year period in one cohort of patients undergoing long-term peritoneal dialysis (PD) therapy. Methods The participants in this study
Autor:
Mei-Chen Chao, Chien-Hsing Wu, Hong-Tao Yang, Jin-Bor Chen, Pei-Ling Liang, Na Hao, Terry Ting-Yu Chiou, Yang-Yang Lei
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2019 (2019)
BioMed Research International, Vol 2019 (2019)
Patients on peritoneal dialysis (PD) encounter peritoneal functional and structural alterations. It is still unknown whether levels of plasminogen activator inhibitor type 1 (PAI-1), matrix metalloproteinases- (MMP-) 2, and vascular endothelial growt
Autor:
Terry Ting-Yu Chiou, Jin-Bor Chen, Hwee-Yeong Ng, Po-Jung Wu, Shu-Ching Lien, Pei-Ying Tsai, Wen-Chin Lee, Chien-Hsing Wu, Chien-Te Lee
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2018 (2018)
BioMed Research International, Vol 2018 (2018)
Introduction. Nonalcoholic fatty liver disease (NAFLD) is becoming more common around the world and it may progress to cirrhosis and liver failure, increasing mortality risk. In hemodialysis (HD) patients, NAFLD may be a novel risk factor for their h
Autor:
Shang-Chih Liao, Ben-Chung Cheng, I-Kuan Wang, Yu-Tzu Chang, Shih Yuan Hung, Jin-Bor Chen, An Bang Wu, Chin Chung Tseng, Chiu-Ching Huang
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0190079 (2018)
PLoS ONE
PLoS ONE
Background Encapsulating peritoneal sclerosis (EPS) is a rare but serious complication of long-term peritoneal dialysis (PD). However, previous studies reported large variations in its mortality rates that may associate with a different degree of EPS
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2018 (2018)
BioMed Research International, Vol 2018 (2018)
Background. Apheresis treatment includes plasmapheresis (PP) and plasma exchange (PE), and these terms are commonly used interchangeably. Nevertheless, the two procedures are carried out differently. The aims of this study were to investigate the mor
Autor:
Wen-Hao Liu, Cheng-Hong Yang, Ben-Chung Cheng, Mao-Young Morgan Fu, Jin-Bor Chen, Sin-Hua Moi, Shang-Chih Liao
Publikováno v:
BMC Nephrology
BMC Nephrology, Vol 19, Iss 1, Pp 1-9 (2018)
BMC Nephrology, Vol 19, Iss 1, Pp 1-9 (2018)
Background This study aimed to evaluate the longitudinal changes in cardiac structure and function in incident-automated peritoneal dialysis (APD) patients. Methods We conducted a 2-year prospective, randomized, open-label, parallel-group study to co
Autor:
Yi-Hao Yen, Kuo-Chin Chang, Ming-Chao Tsai, Po-Lin Tseng, Tsung-Hui Hu, Ming-Tsung Lin, Cheng-Kun Wu, Jin-Bor Chen, Ben-Chung Cheng, Jung-Fu Chen
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 4, p e0176027 (2017)
PLoS ONE, Vol 12, Iss 4, p e0176027 (2017)
Background and aims Controlled attenuation parameter (CAP) is a non-invasive method for measuring hepatic steatosis (HS). Non-alcoholic fatty liver disease (NAFLD) is closely related to cardiovascular diseases (CVDs). CVDs are the leading cause of mo